Scores of Generic Medications Recalled Over Quality Issues
WASHINGTON — Nearly 40 different generic medications have been voluntarily recalled by Glenmark Pharmaceuticals after regulators flagged issues related to how the drugs were manufactured in India, the Food and Drug Administration announced Friday.
To ensure the safety and uniformity of medicines, the FDA has imposed what it calls its Current Good Manufacturing Practice standards.
In this case, a deviation from those standards has resulted in a Class II recall, meaning that someone ingesting the medications could experience temporary or medically reversible side effects, but is unlikely to suffer serious harm.
The recalled medications are used to treat a variety of common conditions, including heart disease, high cholesterol, diabetes, epilepsy, psychiatric disorders, and various types of pain and infections.
A full list of the recalled medications can be found here.
Patients using the recalled medications are advised to continue their treatment and contact their pharmacist, physician or medical provider to discuss alternative options.
Consumers with questions regarding this recall should contact Glenmark Pharmaceuticals Inc. at 877-538-8445 between 9 a.m. and 5 p.m. EST Monday through Friday.
Dan can be reached at [email protected] and @DanMcCue
We're proud to make our journalism accessible to everyone, but producing high-quality journalism comes at a cost. That's why we need your help. By making a contribution today, you'll be supporting TWN and ensuring that we can keep providing our journalism for free to the public.
Donate now and help us continue to publish TWN’s distinctive journalism. Thank you for your support!
